Titre : Maladie veno-occlusive hépatique

Maladie veno-occlusive hépatique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Young Adult
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Maladie veno-occlusive hépatique : Questions médicales les plus fréquentes", "headline": "Maladie veno-occlusive hépatique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Maladie veno-occlusive hépatique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-08-05", "dateModified": "2025-05-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Maladie veno-occlusive hépatique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies vasculaires", "url": "https://questionsmedicales.fr/mesh/D014652", "about": { "@type": "MedicalCondition", "name": "Maladies vasculaires", "code": { "@type": "MedicalCode", "code": "D014652", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907" } } }, "about": { "@type": "MedicalCondition", "name": "Maladie veno-occlusive hépatique", "alternateName": "Hepatic Veno-Occlusive Disease", "code": { "@type": "MedicalCode", "code": "D006504", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Marc Humbert", "url": "https://questionsmedicales.fr/author/Marc%20Humbert", "affiliation": { "@type": "Organization", "name": "INSERM UMR_S 999, Pulmonary Arterial Hypertension: Physiopathology and Therapeutic Innovation, Marie Lannelongue Hospital, Le Plessis-Robinson, France; Department of Respiratory Medicine, University Paris-Sud, Medical School, University Paris-Saclay, Hôpitaux de Paris, National Reference Center for Severe Pulmonary Hypertension, Bicêtre Hospital, Le Kremlin Bicêtre, France." } }, { "@type": "Person", "name": "David Montani", "url": "https://questionsmedicales.fr/author/David%20Montani", "affiliation": { "@type": "Organization", "name": "INSERM UMR_S 999, Pulmonary Arterial Hypertension: Physiopathology and Therapeutic Innovation, Marie Lannelongue Hospital, Le Plessis-Robinson, France; Department of Respiratory Medicine, University Paris-Sud, Medical School, University Paris-Saclay, Hôpitaux de Paris, National Reference Center for Severe Pulmonary Hypertension, Bicêtre Hospital, Le Kremlin Bicêtre, France. Electronic address: david.montani@aphp.fr." } }, { "@type": "Person", "name": "Frédéric Perros", "url": "https://questionsmedicales.fr/author/Fr%C3%A9d%C3%A9ric%20Perros", "affiliation": { "@type": "Organization", "name": "INSERM UMR_S 999, Pulmonary Arterial Hypertension: Physiopathology and Therapeutic Innovation, Marie Lannelongue Hospital, Le Plessis-Robinson, France." } }, { "@type": "Person", "name": "Peter Dorfmüller", "url": "https://questionsmedicales.fr/author/Peter%20Dorfm%C3%BCller", "affiliation": { "@type": "Organization", "name": "Department of Pathology, University Hospital Giessen/Marburg and German Centre for Lung Research, Giessen, Germany." } }, { "@type": "Person", "name": "Federico Ravaioli", "url": "https://questionsmedicales.fr/author/Federico%20Ravaioli", "affiliation": { "@type": "Organization", "name": "Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Bologna, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Myeloproliferative neoplasms in adolescents and young adults.", "datePublished": "2022-08-14", "url": "https://questionsmedicales.fr/article/36333071", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.beha.2022.101374" } }, { "@type": "ScholarlyArticle", "name": "Hypertriglyceridemia in young adults with a 22q11.2 microdeletion.", "datePublished": "2022-05-19", "url": "https://questionsmedicales.fr/article/35521712", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1530/EJE-21-1104" } }, { "@type": "ScholarlyArticle", "name": "Adolescent and Young Adult Communication Preferences.", "datePublished": "2022-11-16", "url": "https://questionsmedicales.fr/article/36383117", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1089/jayao.2022.0087" } }, { "@type": "ScholarlyArticle", "name": "Thoughts of young adults with Down syndrome.", "datePublished": "2022-07-09", "url": "https://questionsmedicales.fr/article/36428048", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.apnu.2022.06.006" } }, { "@type": "ScholarlyArticle", "name": "Adrenal crises in adolescents and young adults.", "datePublished": "2022-05-18", "url": "https://questionsmedicales.fr/article/35583847", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12020-022-03070-3" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies cardiovasculaires", "item": "https://questionsmedicales.fr/mesh/D002318" }, { "@type": "ListItem", "position": 3, "name": "Maladies vasculaires", "item": "https://questionsmedicales.fr/mesh/D014652" }, { "@type": "ListItem", "position": 4, "name": "Maladie veno-occlusive hépatique", "item": "https://questionsmedicales.fr/mesh/D006504" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Maladie veno-occlusive hépatique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Maladie veno-occlusive hépatique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Maladie veno-occlusive hépatique", "description": "Comment diagnostiquer la maladie veno-occlusive hépatique ?\nQuels tests sont utilisés pour évaluer la fonction hépatique ?\nLes imageries sont-elles utiles dans le diagnostic ?\nQuels signes cliniques orientent vers cette maladie ?\nLa biopsie est-elle toujours nécessaire ?", "url": "https://questionsmedicales.fr/mesh/D006504?mesh_terms=Young+Adult&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Maladie veno-occlusive hépatique", "description": "Quels sont les symptômes courants de cette maladie ?\nL'ascite est-elle un symptôme fréquent ?\nPeut-on avoir des troubles de la coagulation ?\nLa douleur abdominale est-elle spécifique ?\nLes symptômes peuvent-ils varier selon les patients ?", "url": "https://questionsmedicales.fr/mesh/D006504?mesh_terms=Young+Adult&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Maladie veno-occlusive hépatique", "description": "Comment prévenir la maladie veno-occlusive hépatique ?\nLes vaccinations sont-elles importantes ?\nFaut-il éviter certains médicaments ?\nL'alimentation joue-t-elle un rôle ?\nLe suivi médical est-il essentiel ?", "url": "https://questionsmedicales.fr/mesh/D006504?mesh_terms=Young+Adult&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Maladie veno-occlusive hépatique", "description": "Quels traitements sont disponibles pour cette maladie ?\nLes anticoagulants sont-ils utilisés ?\nLa greffe de foie est-elle une option ?\nY a-t-il des traitements symptomatiques ?\nLes soins de soutien sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D006504?mesh_terms=Young+Adult&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Maladie veno-occlusive hépatique", "description": "Quelles sont les complications possibles ?\nL'insuffisance hépatique est-elle grave ?\nLes infections sont-elles fréquentes ?\nPeut-on développer un cancer du foie ?\nL'hypertension portale peut-elle causer des saignements ?", "url": "https://questionsmedicales.fr/mesh/D006504?mesh_terms=Young+Adult&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Maladie veno-occlusive hépatique", "description": "Quels sont les principaux facteurs de risque ?\nLa consommation d'alcool est-elle un facteur ?\nLes antécédents familiaux jouent-ils un rôle ?\nLes infections virales sont-elles un risque ?\nLe surpoids est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D006504?mesh_terms=Young+Adult&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la maladie veno-occlusive hépatique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins, échographies et biopsies hépatiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la fonction hépatique ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests hépatiques incluent les transaminases, la bilirubine et l'albumine." } }, { "@type": "Question", "name": "Les imageries sont-elles utiles dans le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'échographie et l'IRM peuvent montrer des anomalies vasculaires dans le foie." } }, { "@type": "Question", "name": "Quels signes cliniques orientent vers cette maladie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent l'hépatomégalie, l'ascite et les troubles de la coagulation." } }, { "@type": "Question", "name": "La biopsie est-elle toujours nécessaire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, mais elle peut confirmer le diagnostic en cas de doute." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de cette maladie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, douleur abdominale, et jaunisse." } }, { "@type": "Question", "name": "L'ascite est-elle un symptôme fréquent ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'ascite est fréquente et résulte de l'hypertension portale." } }, { "@type": "Question", "name": "Peut-on avoir des troubles de la coagulation ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de la coagulation peuvent survenir en raison de l'insuffisance hépatique." } }, { "@type": "Question", "name": "La douleur abdominale est-elle spécifique ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "La douleur abdominale est souvent diffuse et peut être associée à l'hépatomégalie." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils varier selon les patients ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la nature des symptômes peuvent varier d'un patient à l'autre." } }, { "@type": "Question", "name": "Comment prévenir la maladie veno-occlusive hépatique ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut la gestion des facteurs de risque et un suivi médical régulier." } }, { "@type": "Question", "name": "Les vaccinations sont-elles importantes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, se vacciner contre l'hépatite peut réduire le risque de complications hépatiques." } }, { "@type": "Question", "name": "Faut-il éviter certains médicaments ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments hépatotoxiques doivent être évités pour protéger le foie." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée peut aider à maintenir la santé hépatique." } }, { "@type": "Question", "name": "Le suivi médical est-il essentiel ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi médical régulier permet de détecter précocement les problèmes hépatiques." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour cette maladie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des médicaments, des transfusions et parfois une greffe de foie." } }, { "@type": "Question", "name": "Les anticoagulants sont-ils utilisés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anticoagulants peuvent être prescrits pour réduire le risque de thrombose." } }, { "@type": "Question", "name": "La greffe de foie est-elle une option ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la greffe de foie est envisagée en cas d'insuffisance hépatique sévère." } }, { "@type": "Question", "name": "Y a-t-il des traitements symptomatiques ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements symptomatiques comme les diurétiques pour l'ascite sont utilisés." } }, { "@type": "Question", "name": "Les soins de soutien sont-ils importants ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les soins de soutien sont cruciaux pour améliorer la qualité de vie des patients." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance hépatique, l'hypertension portale et les infections." } }, { "@type": "Question", "name": "L'insuffisance hépatique est-elle grave ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'insuffisance hépatique peut être fatale si elle n'est pas traitée rapidement." } }, { "@type": "Question", "name": "Les infections sont-elles fréquentes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients peuvent être plus susceptibles aux infections en raison de l'immunosuppression." } }, { "@type": "Question", "name": "Peut-on développer un cancer du foie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de développer un cancer du foie augmente avec l'insuffisance hépatique chronique." } }, { "@type": "Question", "name": "L'hypertension portale peut-elle causer des saignements ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'hypertension portale peut entraîner des varices œsophagiennes et des saignements." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la chimiothérapie, les maladies hépatiques préexistantes et l'obésité." } }, { "@type": "Question", "name": "La consommation d'alcool est-elle un facteur ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une consommation excessive d'alcool peut augmenter le risque de maladies hépatiques." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies hépatiques peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les infections virales sont-elles un risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections virales comme l'hépatite B et C sont des facteurs de risque importants." } }, { "@type": "Question", "name": "Le surpoids est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le surpoids et l'obésité sont associés à un risque accru de maladies hépatiques." } } ] } ] }

Sources (10000 au total)

Hypertriglyceridemia in young adults with a 22q11.2 microdeletion.

Mild to moderate hypertriglyceridemia is a condition often associated with obesity and diabetes, with as yet incomplete knowledge of underlying genetic architecture. The 22q11.2 microdeletion is assoc... This was a cohort study comparing 6793 population-based adults and 267 with a 22q11.2 microdeletion aged 17-69 years, excluding those with diabetes or on statins.... We used binomial logistic regression modeling to identify predictors of hypertriglyceridemia, accounting for the 22q11.2 microdeletion, male sex, BMI, ethnicity, age, and antipsychotic medications.... The 22q11.2 microdeletion was a significant independent predictor of mild to moderate hypertriglyceridemia (odds ratio (OR): 2.35, 95% CI: 1.70-3.26). All other factors examined were also significant ... The 22q11.2 microdeletion is associated with hypertriglyceridemia even when accounting for other known risk factors for elevated triglycerides. This effect is seen in young adulthood (76.6% were <40 y...

Thoughts of young adults with Down syndrome.

This study aimed to obtain information about the thoughts of young adults with Down syndrome through interviews of them.... The numbers of participants were 4 and 7 in order to group interviews and individual interviews. They were recruited through the local Association of Parents of Down syndrome. The study incorporated a... Through analysis, six themes emerged: 1) thoughts about work, 2) existence of friends, 3) how to spend leisure time, 4) meaning of disability, 5) relationships with people, and 6) future dreams.... 1) Although young adults with Down syndrome are serious about their work, it is difficult for them to make friends at work. However, they recognized people at work as their comrades and were encourage...

Adrenal crises in adolescents and young adults.

Review the literature concerning adrenal insufficiency (AI) and adrenal crisis (AC) in adolescents and young adults.... Searches of PubMed identifying relevant reports up to March 2022.... AI is rare disorder that requires lifelong glucocorticoid replacement therapy and is associated with substantial morbidity and occasional mortality among adolescents and young adults. Aetiologies in t... In this review, we examine the current state of knowledge of AC epidemiology in emerging adults; examine the causes of ACs in this age group; and suggest areas for further investigation that are aimed...

Ischemic Stroke in Young Tunisian Adults.

Ischemic Stroke in young adults is a real public health problem; it's a major cause of disability, alters quality of life and has a great socio-economic impact.... determine risk factors and specify the etiology of arterial ischemic stroke in young Tunisian adults.... In this 5 years retrospective study (2015-2020), we included all young adults (18-50 years) admitted for arterial ischemic stroke (AIS). Risk factors were registered and analyzed. All patients were in... We collected 200 patients with AIS. The mean age was 41.37 years ± 6.99. Traditional vascular risk factors were observed in more than 1⁄4 patients. A definite cause of stroke was identified in 120 pat... Through this study, we demonstrated the diversity of etiology of stroke in young Tunisian adults. Changes of lifestyle are responsible for the occurrence of the traditional risk factors at an early ag...

Primary Hyperparathyroidism in Young Adult Patients.

Primary hyperparathyroidism (PHPT) affects 2% of Americans over 55 years of age, and is less common in younger patients. Pediatric PHPT patients have higher rates of multigland disease (MGD). We studi... Retrospective chart review was performed on patients who underwent parathyroidectomy for PHPT (2000-2019). Cohorts were defined by age: Group A (18-40 years) and Group B (> 40 years). Univariate and m... Of 3889 patients with PHPT, 9.1% (n = 352) were included in Group A. On multivariate analysis, multiple endocrine neoplasia (odds ratio [OR] 6.3, 95% confidence interval [CI] 3.1-12.7), male sex (OR 1... In our population of patients with sporadic PHPT, a positive family history of PHPT was strongly associated with MGD; additional associations were found with prior parathyroidectomy, non-localizing im...